Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir
Sign Up to like & getrecommendations! Published in 2019 at "Liver International"
DOI: 10.1111/liv.14017
Abstract: Tenofovir disoproxil fumarate (TDF) is recommended for chronic hepatitis B (CHB) treatment, but it may induce kidney dysfunction whose management is not yet known. This Italian, multicentre, retrospective study aimed to assess the efficacy and… read more here.
Keywords: tenofovir; hepatitis; dysfunction; kidney dysfunction ... See more keywords